www.cancertherapyadvisor.com
Open in
urlscan Pro
2606:4700::6812:3ad
Public Scan
Submitted URL: http://cancertherapyadvisor.com/
Effective URL: https://www.cancertherapyadvisor.com/
Submission: On June 22 via manual from US — Scanned from DE
Effective URL: https://www.cancertherapyadvisor.com/
Submission: On June 22 via manual from US — Scanned from DE
Form analysis
2 forms found in the DOMhttps://www.cancertherapyadvisor.com/
<form class="search focus-label" id="mobile-search" aria-hidden="true" action="https://www.cancertherapyadvisor.com/" aria-expanded="false">
<input class="searchinput predictive-search" id="q" type="text" value="" name="s">
<label class="searchformlabel " id="q-label" for="q"> Search... </label>
<button class="submit" type="submit">
<span class="searchicon">
<svg role="presentation" class="icon icon--search" aria-label="search">
<use xlink:href="https://www.cancertherapyadvisor.com/wp-content/themes/haymarket/assets/svg/src.svg?ver=1666876545#search"></use>
</svg> </span>
<span class="screen-reader-text">Submit</span>
</button>
</form>
<form class="HMIRegistration__form ismedical" novalidate="">
<div class="HMIRegistration__row ">
<div class="HMIRegistration__column u-col12">
<div class="HMIRegistration__form-control HMIRegistration__input "><input class="form-control" type="email" id="root_email" label="email" placeholder="*E-mail Address" value=""></div>
</div>
</div>
<div class="HMIRegistration__row ">
<div class="HMIRegistration__column u-col12">
<div class="HMIRegistration__form-control HMIRegistration__input "><input class="form-control" type="password" id="root_password" label="password" placeholder="*Password" value=""></div>
</div>
</div>
<div class="HMIRegistration__row ">
<div class="HMIRegistration__column u-col12">
<div class="HMIRegistration__checkbox"><span class="HMIRegistration__sprite"><span class="HMIRegistration__sprite-border "></span><span class="HMIRegistration__sprite-checkmark "><svg width="15" height="15" class="widget-svg">
<path class="checkmark" d="M5.6,13.4C3.7,11.6,1.9,9.8,0,8c0.8-0.8,1.6-1.6,2.3-2.3c1.1,1,2.2,2.1,3.3,3.1c2.4-2.4,4.7-4.8,7-7.2 c0.8,0.8,1.5,1.6,2.3,2.3C11.9,7,8.8,10.2,5.6,13.4z"></path>
</svg></span><span class="HMIRegistration__sprite-fill "></span></span><span class="HMIRegistration__text ">Keep me signed in</span></div>
</div>
</div>
<p class="HMIRegistration__text linkToForgetPword ismedical"><a href="#" class="HMIRegistration__link ismedical" data-feathr-click-track="true" data-feathr-link-aids="["5ac50f6bf60e8103ce30c554"]">Forgot your password?</a></p><button
class="HMIRegistration__submit ismedical" type="submit">Login</button>
<p class="HMIRegistration__text goToRegister ismedical">
<a href="#" class="HMIRegistration__link ismedical" data-feathr-click-track="true" data-feathr-link-aids="["5ac50f6bf60e8103ce30c554"]">Do not have an account yet?<strong> Register</strong></a></p>
</form>
Text Content
Skip to navigation Skip to main content Menu Close Search... Submit * Breast * CML * Gastrointestinal * GYN * Lung * Multiple Myeloma * Prostate * RCC * Skin * MoreOpen Submenu * More Back * Bladder Cancer * Bone Cancer * Brain Cancer * Chronic Lymphocytic Leukemia * Endocrine Cancer * General Medicine * General Oncology * Head and Neck Cancer * Hematologic Cancers * Lymphoma * Pancreatic Cancer * Pediatric Cancer * Practice Management * Sarcoma * Supportive Care * Urologic Cancers Toggle Search Menu * Headlines * Drugs * Conferences * Cancer Management * Clinical Resources * Tools * Multimedia * CME * Jobs Advertisement Login Register * Get the App * Submit Cases * * * TOP NEWS MORE CANCER SURVIVORS ARE BEING DIAGNOSED WITH NEW CANCERS FOLFOXIRI-BEVACIZUMAB DEEMED OPTIMAL FOR CERTAIN PATIENTS WITH CRC LIVER METASTASES HDC-ASCT IMPROVES SURVIVAL VS IMMUNOCHEMOTHERAPY IN PRIMARY CNS LYMPHOMA FOOD-DRUG INTERACTION COULD COMPROMISE EFFICACY OF ALECTINIB TALZENNA COMBO APPROVED FOR HRR GENE-MUTATED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER NATIONAL HEALTH SPENDING SET TO INCREASE THROUGH 2031 CHANGES TO PRIMARY ENDPOINTS OF ICI TRIALS ARE NOT BEING DISCLOSED SUNVOZERTINIB SHOWS ACTIVITY IN NSCLC PATIENTS AFTER PLATINUM CHEMO FAILURE ACALABRUTINIB PLUS RITUXIMAB “HIGHLY EFFECTIVE” IN OLDER MCL PATIENTS MORTALITY RATES HAVE DECREASED FOR WOMEN WITH EARLY INVASIVE BREAST CANCER OUTCOMES OF UNRELATED, HAPLO TRANSPLANT IN AML HAVE IMPROVED OVER TIME SURVEY: MOST AMERICANS HAVE PROBLEMS WITH THEIR HEALTH INSURANCE PLANS More » EDITORIAL ADVISORY BOARD Barbara Ann Burtness, MD Steven Cohen, MD E. David Crawford, MD Don S. Dizon, MD, FACP Jeffrey M. Farma, MD Neal D. Shore, MD, FACS Mark A. Socinski, MD Mario Sznol, MD Click here for complete profiles FEATURED Previous 1 / 6 Next UPDATE ON BLADDER CANCER RISK FACTORS A recent review provided an update on traditional and novel risk factors for bladder cancer that may help guide prevention efforts. ASCO 2023: STUDIES CLARIFY ROLE OF IMMUNOTHERAPY IN MULTIPLE MYELOMA Studies from ASCO 2023 revealed new potential standards of care for multiple myeloma and a first for bispecific antibody therapy. ICML 2023 News from the International Conference on Malignant Lymphoma EHA 2023 News from the EHA 2023 Hybrid Congress ASCO 2023 News from the ASCO Annual Meeting 2023 OPINION: SURGEON COLLABORATION IS KEY TO MITIGATING POST-MASTECTOMY CHEST NUMBNESS Breast surgeons and plastic reconstructive surgeons should work together to care for nerves in the breasts during breast cancer surgery. UPDATE ON BLADDER CANCER RISK FACTORS A recent review provided an update on traditional and novel risk factors for bladder cancer that may help guide prevention efforts. ASCO 2023: STUDIES CLARIFY ROLE OF IMMUNOTHERAPY IN MULTIPLE MYELOMA Studies from ASCO 2023 revealed new potential standards of care for multiple myeloma and a first for bispecific antibody therapy. ICML 2023 News from the International Conference on Malignant Lymphoma EHA 2023 News from the EHA 2023 Hybrid Congress ASCO 2023 News from the ASCO Annual Meeting 2023 OPINION: SURGEON COLLABORATION IS KEY TO MITIGATING POST-MASTECTOMY CHEST NUMBNESS Breast surgeons and plastic reconstructive surgeons should work together to care for nerves in the breasts during breast cancer surgery. UPDATE ON BLADDER CANCER RISK FACTORS A recent review provided an update on traditional and novel risk factors for bladder cancer that may help guide prevention efforts. * * * * * * MORE FEATURES STATE OF CANCER RESEARCH: IMPACT OF COVID-19, BREXIT, WAR, AND OTHER GLOBAL EVENTS By Victoria Forster, PhD AACR 2023 HIGHLIGHTS NOVEL RESEARCH IN NSCLC AND ES-SCLC By Tori Rodriguez, MA, LPC, AHC LACK OF ACCESS TO ABORTION HAS HAD A NEGATIVE IMPACT ON CANCER CARE By Tori Rodriguez, MA, LPC, AHC GLOBAL SURVEY SUGGESTS RCC PATIENTS ARE UNDERINFORMED, FACE OBSTACLES TO CARE By Alan P. Lyss, MD IBRUTINIB NO LONGER APPROVED FOR MCL, MZL: HOW THIS CHANGE WILL AFFECT PATIENTS By Mary Ellen Schneider More Features » FACT SHEETS FACT SHEET: COVID-19 VACCINE CONSIDERATIONS FOR PATIENTS WITH CANCER WHAT TO EXPECT: ENROLLING ON A CANCER CLINICAL TRIAL DURING COVID-19 More » * Registered users get free access to premium features like: * A personalized onsite experience * Your top three articles, curated onsite daily * Unlimited access to our expert content REGISTER Already have an account? Sign in here * Advertisement * Loading... Popular in Cancer Therapy siteName Cancer Therapy Advisor siteURL https://www.cancertherapyadvisor.com siteID 12 First-Line Pembrolizumab Improves Survival in Metastatic Cervical Cancer Colby Stong 5 June 2023 cancertherapyadvisor.com Updated data support the use of pembrolizumab in combination with chemotherapy as first-line standard care for patients … siteName Cancer Therapy Advisor siteURL https://www.cancertherapyadvisor.com siteID 12 Zanidatamab Yields Durable Responses in HER2+ Biliary Tract Cancer James Nam, PharmD 4 June 2023 cancertherapyadvisor.com Zanidatamab can produce rapid and durable responses in patients with advanced HER2-positive biliary tract cancer, phase 2 data suggest. siteName Cancer Therapy Advisor siteURL https://www.cancertherapyadvisor.com siteID 12 Ultrasound Technique Delivers Paclitaxel Across Blood-Brain Barrier in Glioblastoma Leah Lawrence 17 May 2023 cancertherapyadvisor.com An ultrasound technique allows for delivery of albumin-bound paclitaxel across the blood-brain barrier in patients with … siteName Cancer Therapy Advisor siteURL https://www.cancertherapyadvisor.com siteID 12 UCPVax Prompts Immune Responses in MGMT Unmethylated Glioblastoma Bryant Furlow 4 June 2023 cancertherapyadvisor.com UCPVax, an anti-telomerase vaccine, has demonstrated immunogenicity in a phase 2 trial of patients with MGMT unmethylated glioblastoma. siteName Cancer Therapy Advisor siteURL https://www.cancertherapyadvisor.com siteID 12 Menstrual Disturbances Not Being Tracked, Treated in Cancer Patients Leah Lawrence 24 April 2023 cancertherapyadvisor.com New research suggests that some cancer patients do not have their menstrual history documented and do not receive treatm… siteName Cancer Therapy Advisor siteURL https://www.cancertherapyadvisor.com siteID 12 High TMB Associated With Better Outcomes of ICI Therapy in Advanced Cancers Leah Lawrence 16 May 2023 cancertherapyadvisor.com Patients with advanced cancer have better outcomes if they have high TMB prior to treatment with an ICI, new research suggests. * Advertisement * Loading... Continuing Medical Education (CME/CE) Courses siteName Cancer Therapy Advisor siteURL https://www.cancertherapyadvisor.com siteID 12 Pearls for Management of Common Pediatric Disorders: Who’s at Risk of “Tridemic” Impacts? Haymarket Media 26 May 2023 mycme.com siteName Cancer Therapy Advisor siteURL https://www.cancertherapyadvisor.com siteID 12 From Recognition to Refractory Care: Management of Pulmonary MAC Haymarket Media 6 June 2023 mycme.com siteName Cancer Therapy Advisor siteURL https://www.cancertherapyadvisor.com siteID 12 Childhood Interstitial Lung Diseases: Increasing Awareness, Diagnosis, and Multidisciplinary Patient Management Haymarket Media 9 June 2023 mycme.com siteName Cancer Therapy Advisor siteURL https://www.cancertherapyadvisor.com siteID 12 Optimizing Outcomes in ALS: Best Practices in Screening, Diagnosis, and Treatment Haymarket Media 13 June 2023 mycme.com siteName Cancer Therapy Advisor siteURL https://www.cancertherapyadvisor.com siteID 12 Rett Syndrome Update: Evolving Management Strategies Haymarket Media 1 June 2023 mycme.com siteName Cancer Therapy Advisor siteURL https://www.cancertherapyadvisor.com siteID 12 A New Era in Small Cell Lung Cancer: Progress in Immunotherapy for Extensive Stage Disease Haymarket Media 24 May 2023 mycme.com Show More * Advertisement Back to Top * CancerTherapyAdvisor.com is a free online resource that offers oncology healthcare professionals a comprehensive knowledge base of practical oncology information and clinical tools to assist in making the right decisions for their patients. Our mission is to provide practice-focused clinical and drug information that is reflective of current and emerging principles of care that will help to inform oncology decisions. * Do Not Sell or Share My Personal Information * * * * RESOURCES * Submissions * Advisory Board * Useful Links * Reprints/Permissions * USER CENTER * About Us * Advertise * Contact Us * Staff * OTHER HAYMARKET MEDICAL WEBSITES * Clinical Advisor * Clinical Pain Advisor * Dermatology Advisor * Endocrinology Advisor * Gastroenterology Advisor * Hematology Advisor * Infectious Disease Advisor * McKnight’s Long Term Care News * McKnight’s Senior Living * Medical Bag * MPR * myCME * Neurology Advisor * Oncology Nurse Advisor * Ophthalmology Advisor * Optometry Advisor * Psychiatry Advisor * Pulmonology Advisor * Rare Disease Advisor * Renal and Urology News * Rheumatology Advisor * The Cardiology Advisor * Copyright © 2023 Haymarket Media, Inc. All Rights Reserved This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms & Conditions. Some areas of this page may shift around if you resize the browser window. Be sure to check heading and document order. Close more info about Home LOG IN TO CANCER THERAPY ADVISOR PLEASE LOG IN USING YOUR PASSWORD. *Required Keep me signed in Forgot your password? Login Do not have an account yet? Register Close more info about Home JOIN THE CREATING YOUR FREE ACCOUNT WITH CANCER THERAPY ADVISOR ALLOWS YOU ACCESS TO EXCLUSIVE CONTENT, INCLUDING CASE STUDIES, DRUG INFORMATION, CME AND MORE ACROSS OUR GROWING NETWORK OF CLINICAL SITES. *Required *ProfessionCertified Diabetes EducatorClinical Nurse SpecialistConsumer / PatientDentistDietitian / NutritionistGenetic CounselorNurseNurse PractitionerOptometristOther Healthcare ProfessionalPharmacistPhysicianPhysician AssistantPsychologistResidentSocial WorkerStudent *SpecialtyAllergy / ImmunologyAnesthesiologyBariatric MedicineCardiologyComplementary / Alternative MedicineCritical Care MedicineDentalDermatologyDiabetesEmergency MedicineEndocrinologyFamily Medicine / General PracticeGastroenterology / ProctologyGeriatric MedicineHematologyHematology / OncologyHospitalistInfectious DiseaseInfusion TherapyInternal MedicineLong-Term CareNephrologyNeurologyNutritionObstetrics / GynecologyOncologyOphthalmologyOptometryOrthopedicsOtolaryngologyPain MedicinePathologyPediatricsPharmacyPhysical Medicine / RehabilitationPsychiatryPublic Health / Preventive MedicinePulmonologyRadiology / Nuclear MedicineRheumatologySports MedicineSurgeryUrologyOther *CountryUnited States --State--AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWashington, D.C.West VirginiaWisconsinWyoming REGISTER FOR EMAIL NEWSLETTERS Cancer Therapy Advisor Weekly Highlights Cancer Therapy Advisor Daily Update Register Already have an account with one of our brands? LOG IN Terms and Conditions | Privacy Policy word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word word mmMwWLliI0fiflO&1 mmMwWLliI0fiflO&1 mmMwWLliI0fiflO&1 mmMwWLliI0fiflO&1 mmMwWLliI0fiflO&1 mmMwWLliI0fiflO&1 mmMwWLliI0fiflO&1 DO NOT SELL OR SHARE MY PERSONAL DATA When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link. More information Accept MANAGE CONSENT PREFERENCES STRICTLY NECESSARY COOKIES Always Active These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information. * FUNCTIONAL COOKIES Always Active These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly. DO NOT SELL PERSONAL INFORMATION Do Not Sell Personal Information * SOCIAL MEDIA COOKIES Switch Label label These cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools. * PERFORMANCE COOKIES Switch Label label These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. * TARGETING COOKIES Switch Label label These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising. Back Button PERFORMANCE COOKIES Search Icon Filter Icon Clear checkbox label label Apply Cancel Consent Leg.Interest Switch Label label Switch Label label Switch Label label Confirm My Choices ABCDEFGHIJKLMNOPQRSTUVWXYZabcdefghijklmnopqrstuvwxyz0123456789-_~ x